Bunny Trail to the Top 10: Q1 2025 Drug & Therapy Classes

At Prodigy, we dig deep into the basket to uncover the most commonly used drugs across our portfolio—and pain management remains the golden egg. NSAIDs, muscle relaxants, and topical anesthetics are helping shift the industry toward smarter, multimodal strategies. While opioids haven’t fully hatched out of the picture, there’s growing momentum around safer alternatives and the need for vigilant clinical oversight.

To sweeten the deal, Prodigy delivers customized Top 10 Drug Reports tailored to each client’s claims experience. These insights help uncover hidden trends, manage costs, and make more informed decisions—no hunting required.

Next
Next

The New Drug Basket: 1Q 2025 FDA Approvals